A new study found that the proportion of people being diagnosed with lung cancer who have never smoked is increasing, and air ...

Lung metastases are a devastating reality for over half of cancer patients whose tumors spread beyond their initial sites.

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its ...

Given the latest data, which includes troubling trends in pancreatic cancer and growing inequities in cancer outcomes for ...

Lung Cancer Test Predicts Survival in Early Stages ... 2024 — A team has discovered a new communication pathway between the gut and lung. Their findings highlight how a little-known member ...

Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 ...

NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.

Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...

Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel ...